Benzamide, N-[(3S,4S)-6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluoro-
| Title | Journal |
|---|---|
| Emerging migraine treatments and drug targets. | Trends in pharmacological sciences 20110601 |
| Design considerations in migraine with aura trials: learning from experience. | Cephalalgia : an international journal of headache 20100901 |
| On the methodology of drug trials in migraine with aura. | Cephalalgia : an international journal of headache 20100901 |
| Tonabersat: a cortical spreading depression inhibitor as potential pharmacologic prophylaxis in migraine with aura. | Current neurology and neuroscience reports 20100101 |
| Neurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine. | Cephalalgia : an international journal of headache 20091101 |
| Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. | Cephalalgia : an international journal of headache 20091101 |
| Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. | Cephalalgia : an international journal of headache 20091101 |
| Tonabersat, a novel gap-junction modulator for the prevention of migraine. | Cephalalgia : an international journal of headache 20091101 |
| Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. | The Lancet. Neurology 20090801 |
| Tonabersat for migraine prevention: new life or last gasp? | The Lancet. Neurology 20090801 |
| Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. | Cephalalgia : an international journal of headache 20090701 |
| 2008: the year in review. | Headache 20090501 |
| Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. | Headache 20090101 |
| Emerging therapies for migraine. | Nature clinical practice. Neurology 20071101 |
| Recent advances in understanding migraine mechanisms, molecules and therapeutics. | Trends in molecular medicine 20070101 |
| Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology. | Disease-a-month : DM 20061001 |
| A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. | Cephalalgia : an international journal of headache 20041001 |
| A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA). | Magnetic resonance imaging 20031101 |
| Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. | Experimental neurology 20011201 |
| Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes. | British journal of pharmacology 20010401 |
| Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. | Brain research 20010209 |